780 related articles for article (PubMed ID: 26170159)
1. Cost-effective alternative to nano-encapsulation: Amorphous curcumin-chitosan nanoparticle complex exhibiting high payload and supersaturation generation.
Nguyen MH; Yu H; Kiew TY; Hadinoto K
Eur J Pharm Biopharm; 2015 Oct; 96():1-10. PubMed ID: 26170159
[TBL] [Abstract][Full Text] [Related]
2. Amorphous ternary nanoparticle complex of curcumin-chitosan-hypromellose exhibiting built-in solubility enhancement and physical stability of curcumin.
Lim LM; Tran TT; Long Wong JJ; Wang D; Cheow WS; Hadinoto K
Colloids Surf B Biointerfaces; 2018 Jul; 167():483-491. PubMed ID: 29727835
[TBL] [Abstract][Full Text] [Related]
3. A supersaturating delivery system of silibinin exhibiting high payload achieved by amorphous nano-complexation with chitosan.
Nguyen MH; Yu H; Dong B; Hadinoto K
Eur J Pharm Sci; 2016 Jun; 89():163-71. PubMed ID: 27140843
[TBL] [Abstract][Full Text] [Related]
4. A new bioavailability enhancement strategy of curcumin via self-assembly nano-complexation of curcumin and bovine serum albumin.
Yu H; Nguyen MH; Cheow WS; Hadinoto K
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():25-33. PubMed ID: 28415461
[TBL] [Abstract][Full Text] [Related]
5. Effects of chitosan molecular weight on the physical and dissolution characteristics of amorphous curcumin-chitosan nanoparticle complex.
Yu H; Nguyen MH; Hadinoto K
Drug Dev Ind Pharm; 2018 Jan; 44(1):82-88. PubMed ID: 28849675
[TBL] [Abstract][Full Text] [Related]
6. Enhancing the stability of amorphous drug-polyelectrolyte nanoparticle complex using a secondary small-molecule drug as the stabilizer: A case study of ibuprofen-stabilized curcumin-chitosan nanoplex.
Lim LM; Hadinoto K
Int J Pharm; 2020 Feb; 575():119007. PubMed ID: 31893545
[TBL] [Abstract][Full Text] [Related]
7. A simple strategy to enhance the in vivo wound-healing activity of curcumin in the form of self-assembled nanoparticle complex of curcumin and oligochitosan.
Nguyen MH; Lee SE; Tran TT; Bui CB; Nguyen TH; Vu NB; Tran TT; Nguyen TH; Nguyen TT; Hadinoto K
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():54-64. PubMed ID: 30813056
[TBL] [Abstract][Full Text] [Related]
8. Amorphous nanoparticle complex of perphenazine and dextran sulfate as a new solubility enhancement strategy of antipsychotic perphenazine.
Dong B; Hadinoto K
Drug Dev Ind Pharm; 2017 Jun; 43(6):996-1002. PubMed ID: 28121189
[TBL] [Abstract][Full Text] [Related]
9. Millifluidic synthesis of amorphous drug-polysaccharide nanoparticle complex with tunable size intended for supersaturating drug delivery applications.
Tran TT; Nguyen MH; Tan YZ; Chew JW; Khan SA; Hadinoto K
Eur J Pharm Biopharm; 2017 Mar; 112():196-203. PubMed ID: 27903456
[TBL] [Abstract][Full Text] [Related]
10. Green amorphous nanoplex as a new supersaturating drug delivery system.
Cheow WS; Hadinoto K
Langmuir; 2012 Apr; 28(15):6265-75. PubMed ID: 22439687
[TBL] [Abstract][Full Text] [Related]
11. Controlling the burst release of amorphous drug-polysaccharide nanoparticle complex via crosslinking of the polysaccharide chains.
Nguyen MH; Tran TT; Hadinoto K
Eur J Pharm Biopharm; 2016 Jul; 104():156-63. PubMed ID: 27179586
[TBL] [Abstract][Full Text] [Related]
12. High-Payload Buccal Delivery System of Amorphous Curcumin-Chitosan Nanoparticle Complex in Hydroxypropyl Methylcellulose and Starch Films.
Lim LM; Hadinoto K
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502305
[TBL] [Abstract][Full Text] [Related]
13. Combining inkjet printing and amorphous nanonization to prepare personalized dosage forms of poorly-soluble drugs.
Cheow WS; Kiew TY; Hadinoto K
Eur J Pharm Biopharm; 2015 Oct; 96():314-21. PubMed ID: 26325060
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the physical stability and supersaturation generation of amorphous drug-polyelectrolyte nanoparticle complex via incorporation of crystallization inhibitor at the nanoparticle formation step: A case of HPMC versus PVP.
Dong B; Lim LM; Hadinoto K
Eur J Pharm Sci; 2019 Oct; 138():105035. PubMed ID: 31386892
[TBL] [Abstract][Full Text] [Related]
15. Self-assembled amorphous drug-polyelectrolyte nanoparticle complex with enhanced dissolution rate and saturation solubility.
Cheow WS; Hadinoto K
J Colloid Interface Sci; 2012 Feb; 367(1):518-26. PubMed ID: 22051687
[TBL] [Abstract][Full Text] [Related]
16. Carboxymethyl cellulose is a superior polyanion to dextran sulfate in stabilizing and enhancing the solubility of amorphous drug-polyelectrolyte nanoparticle complex.
Dong B; Hadinoto K
Int J Biol Macromol; 2019 Oct; 139():500-508. PubMed ID: 31386874
[TBL] [Abstract][Full Text] [Related]
17. Characterization and anti-proliferative activity of curcumin loaded chitosan nanoparticles in cervical cancer.
Khan MA; Zafaryab M; Mehdi SH; Ahmad I; Rizvi MM
Int J Biol Macromol; 2016 Dec; 93(Pt A):242-253. PubMed ID: 27565296
[TBL] [Abstract][Full Text] [Related]
18. Direct comparison between millifluidic and bulk-mixing platform in the synthesis of amorphous drug-polysaccharide nanoparticle complex.
Dong B; Hadinoto K
Int J Pharm; 2017 May; 523(1):42-51. PubMed ID: 28323097
[TBL] [Abstract][Full Text] [Related]
19. Improving curcumin solubility and bioavailability by encapsulation in saponin-coated curcumin nanoparticles prepared using a simple pH-driven loading method.
Peng S; Li Z; Zou L; Liu W; Liu C; McClements DJ
Food Funct; 2018 Mar; 9(3):1829-1839. PubMed ID: 29517797
[TBL] [Abstract][Full Text] [Related]
20. Preparation of chitosan-coated nanoliposomes for improving the mucoadhesive property of curcumin using the ethanol injection method.
Shin GH; Chung SK; Kim JT; Joung HJ; Park HJ
J Agric Food Chem; 2013 Nov; 61(46):11119-26. PubMed ID: 24175657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
